TCI Wealth Advisors’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2
| Closed | -$6 | – | 2498 |
|
|
2023
Q1 | $6 | Hold |
2
| – | – | ﹤0.01% | 2509 |
|
|
2022
Q4 | $8 | Hold |
2
| – | – | ﹤0.01% | 2478 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2708 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2621 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2567 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 2608 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2657 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2522 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2274 |
|
|
2020
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1713 |
|
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1703 |
|
|
2020
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 1724 |
|
|
2020
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 1831 |
|
|
2019
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1722 |
|
|
2019
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1678 |
|
|
2019
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 1362 |
|
|
2019
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 1353 |
|
|
2018
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 1363 |
|
|
2018
Q3 | $2K | Hold |
2
| – | – | ﹤0.01% | 1109 |
|
|
2018
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 1429 |
|
|
2018
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 1272 |
|
|
2017
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 1308 |
|
|
2017
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 1239 |
|
|
2017
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 1261 |
|
|
2017
Q1 | $3K | Hold |
2
| – | – | ﹤0.01% | 877 |
|
|
2016
Q4 | $1K | Sell |
2
-1
| -33% | -$399 | ﹤0.01% | 1273 |
|
|
2016
Q3 | $1K | Buy |
3
+2
| +200% | +$894 | ﹤0.01% | 1261 |
|
|
2016
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1409 |
|
|
2016
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1433 |
|
|
2015
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1101 |
|
|
2015
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 935 |
|
|
2015
Q2 | $1K | Buy |
+1
| New | +$2.55K | ﹤0.01% | 924 |
|
TCI Wealth Advisors's HTGM Position: Q2 2023 in Review
TCI Wealth Advisors sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q2 2023, closing a stake of 2 shares — an estimated $6 sold.
TCI Wealth Advisors first reported a position in HTGM in Q2 2015 and held it in 32 quarters. The position peaked at $3K in Q1 2017. 0 funds tracked by Wall St. Rank hold HTGM as of Q2 2023.
- TCI Wealth Advisors reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 2 HTG Molecular Diagnostics, Inc. Common Stock shares in Q2 2023, an estimated $6.
- TCI Wealth Advisors first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2015 and held it in 32 quarters.
- TCI Wealth Advisors's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $3K in Q1 2017.
- 0 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.